FDA finds no clear link between popular diabetes, weight-loss drugs and suicidal thoughts
The FDA also noted that current prescribing information for GLP-1 RAs already includes warnings about the risk of suicidal thoughts
The FDA also noted that current prescribing information for GLP-1 RAs already includes warnings about the risk of suicidal thoughts
Subscribe To Our Newsletter & Stay Updated